Nymox Pharmaceutical Reports First Quarter 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HASBROUCK HEIGHTS, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the first quarter of 2014. Nymox reported a net loss of $2,592,816, or $0.07 per share for the quarter ended March 31, 2014, compared to $1,093,906, or $0.03 per share for the quarter ended March 31, 2013. The increase in net loss is due to stock compensation charges of $1,420,185 in 2014 compared to $26,640 in 2013. - See more at: http://www.globenewswire.com/news-release/2014/05/15/636856/10081946/en/Nymox-Reports-First-Quarter-2014-Financial-Results.html#sthash.UWA70dKJ.dpuf

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC